Clinical Trial Update: Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial compares reduced immunosuppression to standard triple therapy in senior kidney transplant recipients, assessing efficacy and safety of the regimen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Renal Transplantation

Snippet

Sponsor: Klemens Budde | Conditions: Immunosuppression After Renal Transplantation | Phase 4 | Status: UNKNOWN